Cyfuse Biomedical Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
22
- Stock Symbol
-
4892
- Share Price
-
$4.61
- (As of Tuesday Closing)
Cyfuse Biomedical General Information
Description
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.
Contact Information
Website
www.cyfusebio.comCorporate Office
- 1F Sumitomo Real Estate Mita Twin Building West Wing
- 3-5-27 Mita, Minato-ku
- Tokyo, 108-6301
- Japan
Corporate Office
- 1F Sumitomo Real Estate Mita Twin Building West Wing
- 3-5-27 Mita, Minato-ku
- Tokyo, 108-6301
- Japan
Cyfuse Biomedical Stock Performance
As of 15-Jul-2025, Cyfuse Biomedical’s stock price is $4.61. Its current market cap is $38.3M with 8.3M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.61 | $4.77 | $2.75 - $9.36 | $38.3M | 8.3M | 151K | -$0.72 |
Cyfuse Biomedical Financials Summary
As of 31-Dec-2024, Cyfuse Biomedical has a trailing 12-month revenue of $360K.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 7,362 | 7,362 | 21,876 | 57,308 |
| Revenue | 360 | 360 | 435 | 2,850 |
| EBITDA | (5,445) | (5,445) | (3,831) | (2,966) |
| Net Income | (5,759) | (5,759) | (4,193) | (3,607) |
| Total Assets | 22,403 | 22,403 | 29,886 | 36,725 |
| Total Debt | 5,431 | 5,431 | 6,474 | 6,926 |
Cyfuse Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cyfuse Biomedical Comparisons
Industry
Financing
Details
Cyfuse Biomedical Competitors (8)
One of Cyfuse Biomedical’s 8 competitors is Lonza Group, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lonza Group | Corporation | Basel, Switzerland | ||||
| 3D Biotek | Corporate Backed or Acquired | Bridgewater, NJ | ||||
| Sutro Biopharma | Formerly VC-backed | South San Francisco, CA | ||||
| Teva Pharmaceutical Industries | Corporation | Tel Aviv, Israel | ||||
| Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada |
Cyfuse Biomedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cyfuse Biomedical Patents
Cyfuse Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024156287-A | Angle adjustment mechanism and puncture device | Pending | 24-Apr-2023 | ||
| JP-2024151045-A | Dispensing device | Pending | 11-Apr-2023 | ||
| JP-2024143092-A | Tray holding mechanism | Pending | 30-Mar-2023 | ||
| EP-4428811-A1 | Fibrosis evaluation method for biological sample | Pending | 10-Mar-2023 | ||
| JP-2024128350-A | Fibrosis evaluation method for biological sample | Pending | 10-Mar-2023 | G06T7/0012 |
Cyfuse Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cyfuse Biomedical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cyfuse Biomedical FAQs
-
When was Cyfuse Biomedical founded?
Cyfuse Biomedical was founded in 2010.
-
Where is Cyfuse Biomedical headquartered?
Cyfuse Biomedical is headquartered in Tokyo, Japan.
-
What is the size of Cyfuse Biomedical?
Cyfuse Biomedical has 22 total employees.
-
What industry is Cyfuse Biomedical in?
Cyfuse Biomedical’s primary industry is Discovery Tools (Healthcare).
-
Is Cyfuse Biomedical a private or public company?
Cyfuse Biomedical is a Public company.
-
What is Cyfuse Biomedical’s stock symbol?
The ticker symbol for Cyfuse Biomedical is 4892.
-
What is the current stock price of Cyfuse Biomedical?
As of 15-Jul-2025 the stock price of Cyfuse Biomedical is $4.61.
-
What is the current market cap of Cyfuse Biomedical?
The current market capitalization of Cyfuse Biomedical is $38.3M.
-
What is Cyfuse Biomedical’s current revenue?
The trailing twelve month revenue for Cyfuse Biomedical is $360K.
-
Who are Cyfuse Biomedical’s competitors?
Lonza Group, 3D Biotek, Sutro Biopharma, Teva Pharmaceutical Industries, and Aspect Biosystems are some of the 8 competitors of Cyfuse Biomedical.
-
What is Cyfuse Biomedical’s annual earnings per share (EPS)?
Cyfuse Biomedical’s EPS for 12 months was -$0.72.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
